Cyprus latest patents query
The latest invention patents collect the data information of Cyprus invention patents from 2000 to 2024, typesetting according to the date of patent publication, including patent number, application date, invention Bibliographic data, abstracts, and specification data of people are convenient for scientific researchers to quickly browse and search for patents.
METHOD FOR THE PREPARATION OF 3- HYDROXYBUTARY ACID GLYCERIDES
UndeterminedCY1125989T1Hydroxybutyric acidButyrate
Owner:KETOLIPIX THERAPEUTICS GMBH
AMINOPYRIMIDINE / PYRAZINE DERIVATIVES AS CTPS1 INHIBITORS
UndeterminedCY1125930T1PyrazinePhysics
Owner:STEP PHARMA SAS
NUCLEIC ACIDS FOR INHIBITING LPA EXPRESSION IN A CELL
UndeterminedCY1125875T1Coronary heart diseaseCardio vascular disease
Owner:SILENCE THERAPEUTICS GMBH
SYSTEM AND METHOD FOR CREATING DIGITAL ASSET TRANSACTIONS WITH ENCODED DETAILS REGARDING THE PURPOSE OF TRANSFER
UndeterminedCY2622B1Pharmacy medicineFinancial transaction
Owner:DASTINO LTD
AZA-HETEROBICYCLIC MAT2A INHIBITORS AND METHODS OF USE FOR CANCER TREATMENT
UndeterminedCY1126026T1AdenosinePharmaceutical medicine
Owner:LES LAB SERVIER SA
COMBINATION THERAPY FOR THE TREATMENT OR PREVENTION OF CANCER TUMORS
UndeterminedCY1126212T1Cancer preventionPharmaceutical drug
Owner:QBIOTICS PTY LTD
IMPROVED T-CELL PRODUCTION METHOD
UndeterminedCY1125790T1Blood componentBiochemistry
Owner:CELGENE CORP
AUTOMATIC OPENING / CLOSING DEVICE FOR THE COVER FRAME OF AN UMBRELLA
UndeterminedCY1126262T1Structural engineeringMagnet
Owner:ROMAN ALBERTO
DRY POWDER PREPARATION CONTAINING A CORTICOSTEROID AND A BETA-ADRENERGENT FOR INHALATION
UndeterminedCY1125616T1AdrenergicInhalation
Owner:CHIESI FARMACEUTICI SPA
HEPATITIS B VIRUS VACCINATION
UndeterminedCY1125736T1VaccinationPharmaceutical drug
Owner:HOOKIPA BIOTECH GMBH
LOW-RATED RELEASE POLY-(GLACTIDE-CO-GLYCOLIDE)
UndeterminedCY1126259T1Polymer sciencePolymer chemistry
Owner:TOLMAR INT LTD
S1P RECEPTOR MODULATORS FOR THE THERAPEUTIC TREATMENT OF MULTIPLE SCLEROSIS
UndeterminedCY1125622T1S1P Receptor ModulatorsTherapeutic treatment
Owner:NOVARTIS AG
VEHICLE INCLUDING A STABILIZER AND THE STABILIZER FOR SUCH A VEHICLE
UndeterminedCY1126248T1Suspension (vehicle)Control theory
Owner:P BERENDE KHOLDING BV
CATHETER FOR GAS SENSOR WITH SEPARATE GAS SAMPLE FLOW
UndeterminedCY1125787T1Exhaust fumesEngineering
Owner:DANFOSS IXA
PROCEDURE FOR THE REMOVAL OF HEAVY METALS FROM LIQUIDS
UndeterminedCY1127187T1Mechanical engineeringHeavy metals
Owner:CPPE CARBON PROCESS & PLANT ENG
OXADIAZASPIRIDE COMPOUNDS FOR THE TREATMENT OF DRUG ABUSE AND ADDICTION
UndeterminedCY1125668T1ReceptorMedicinal chemistry
Owner:ESTEVE FARMASYUTIKALZ S A
DELIVERY SYSTEM FOR A FORKED ENDOPLASTY
UndeterminedCY1126246T1CatheterBiomedical engineering
Owner:TRISTENT DEV
PRODRUGS OF GLUTAMINE ANALOGUES
UndeterminedCY1126301T1Glutamine analogSerine
Owner:JOHNS HOPKINS UNIVERSITY
SYSTEM AND METHODS FOR ACTION AGAINST BIOLOGICAL POLLUTION
UndeterminedCY1126229T1Control systemEngineering
Owner:KONINKLIJKE PHILIPS NV
KEY, LOCK AND LOCKING SYSTEM
UndeterminedCY1125707T1Classical mechanicsStructural engineering
Owner:EVVA SICHERHEITSTECHNOLOGIE GMBH
SYSTEM FOR MONITORING AND MAPPING THE SPOT-TEMPORAL DISTRIBUTION OF FORMATION FLUIDS WITHIN A RESERVOIR AND A UNIT FOR THE INTEGRATION AND PRODUCTION OF A MINING WELL FOR THE EXTRACTION OF FORMATION FLUIDS
UndeterminedCY1125936T1TransceiverControl cell
Owner:ENI SPA
DRILLING DEVICE FOR A DRILLING MACHINE and also that a second rear spring assembly (60), which is not adjacent to the side of the drilling tool, has a disc spring assembly (64).
UndeterminedCY1126271T1Mechanical engineeringDrilling machines
Owner:EURODRILL GMBH
ANTIBODY CONSTRUCTS INVOLVING PSMA AND CD3 DUAL-SPECIFIC T CELLS
UndeterminedCY1125806T1EpitopeAntiendomysial antibodies
Owner:AMGEN RESEARCH (MUNICH) GMBH
FOLDABLE BABY CARRIER
UndeterminedCY1126218T1Structural engineeringMechanical engineering
Owner:MAMAS & PAPAS HLDG
RADIO FREQUENCY DETECTORS WITH FOLDABLE MULTIPLE BLADE ELECTRODES
UndeterminedCY1126261T1Radio frequency energyStructural engineering
Owner:DIROS TECH
ANTI-ADRENOMEDULLIN (ADM) ANTIBODY OR ANTI-ADM ANTIBODY FRAGMENT OR ANTI-ADM SCAFFIN MH-IG FOR PREVENTING OR REDUCING ORGAN DYSFUNCTION OR ORGAN FAILURE IN A PATIENT WITH A CHRONIC OR ACUTE DISEASE OR ACUTE CONDITION
UndeterminedCY1125947T1DiseaseHepatic dysfunction
Owner:ADRENOMED
COMPOUNDS THAT INHIBIT THE MCL-1 PROTEIN
UndeterminedCY1125734T1DiseaseMyeloid leukemia
Owner:AMGEN INC
COMPOUNDS AS MODULATORS OF TLR2 SIGNALING
UndeterminedCY1125824T1Pharmaceutical drugBiochemistry
Owner:NEUROPORE THERAPIES INC
PHARMACEUTICAL PREPARATION
UndeterminedCY1126277T1PyridazineCombinatorial chemistry
Owner:MERCK PATENT GMBH
COMBINATION OF IBUPROFENE AND TRAMADOL FOR PAIN RELIEF
UndeterminedCY1126175T1Use medicationSevere pain
Owner:FARMALIDER
HIGH CONCENTRATION PHARMACEUTICAL PREPARATIONS
UndeterminedCY1126185T1
Owner:F HOFFMANN LA ROCHE & CO AG
RUBBER FLAPS FOR CONTAINER COUPLINGS
UndeterminedCY1125782T1CouplingClassical mechanics
Owner:ALGECIREÑA MASCH & REPAIRS IND SL
DEPOSIT SYSTEMS CONTAINING GLATIRAMER ACETATE
UndeterminedCY1126176T1MS multiple sclerosisPharmacology
Owner:MAPI PHARMA LTD
PYRIDINYL AND PYRASINYL - (AZA)INDOLESULPHONAMIDES
UndeterminedCY1125658T1DiseasePyrazine
Owner:UCB PHARMA GMBH
DUAL-SPECIFIC ANTIBODY CONSTRUCTS FOR CDH3 AND CD3
UndeterminedCY1126161T1Antiendomysial antibodiesBispecific antibody
Owner:AMGEN RESEARCH (MUNICH) GMBH
CAVING PROCESS FOR FUEL-WATER EMULSIONS
UndeterminedCY1126234T1ThermodynamicsCavitation (process)
Owner:NANOSPECTRAL LDA
TRANSDERMAL PHARMACEUTICAL COMPOSITIONS CONTAINING ACTIVE AGENTS
UndeterminedCY1126022T1Active agentPharmaceutical drug
Owner:BESINS HEALTHCARE LUXEMBOURG SARL(LU)
ALCOHOL DERIVATIVES AS KV7 POTASSIUM CHANNELS ACTIVATORS
UndeterminedCY1126203T1Pharmaceutical drugMedicinal chemistry
Owner:H LUNDBECK AS
CRYSTALLINE FORM AND SALT OF 3-(3,5-DICHLORO-4- HYDROXYBENZOYL)-1,1-DIOOXO-2,3-DIHYDRO-1,3- BENZOTHIAZOLE
UndeterminedCY1126305T1ThiazolePharmacy medicine
Owner:FUJI YAKUHIN CO LTD
PHARMACEUTICAL PREPARATION CONTAINING ANTIBODY, CYCLODEXTRIN AND METHIONINE
UndeterminedCY1126169T1AntigenDisease
Owner:UCB BIOPHARMA SPRL
CATHETER INCLUDING A CUTTING ELEMENT
UndeterminedCY1125816T1CatheterBiomedical engineering
Owner:BALTON
METHODS FOR PRODUCING BIOCONJUGATION PRODUCTS OF E. COLI O-ANTIGON POLYSACCHARIDES, COMPOSITIONS THEREOF, AND METHODS OF USING THEM
UndeterminedCY1126228T1ESCHERICHIA COLI ANTIGENCarrier protein
Owner:JANSSEN PHARMACEUTICALS INC
TREATMENT OF PAIN ASSOCIATED WITH CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
UndeterminedCY1126199T1IV ChemotherapyNeuropathic pain
Owner:MEDICON PHARMACEUTICALS INC
PEGYLATED LIPOSOMES FOR DELIVERY OF RNA ENCODING AN IMMUNOGEN
UndeterminedCY1126013T1DiseaseLipofectamine
Owner:GLAXOSMITHKLINE BIOLOGICALS SA
NEW SYNTHESIS OF AKETAMINOPHENE COMPOUND WITHOUT SIDE EFFECTS ON THE LIVER
UndeterminedCY1125656T1Polyoxyethylene castor oilSodium acetate
Owner:INT EDUCATION FOUND
SYSTEMS AND METHODS FOR REAL-TIME VIDEO PROCESSING FROM A MEDICAL IMAGING DEVICE AND DETECTION OF OBJECTS IN VIDEO
UndeterminedCY1126174T1Display deviceVideo processing
Owner:COSMO ARTIFICIAL INTELLIGENCE AI LTD
NEW PROBIOTICS USEFUL FOR ERADICATING HELICOBACTERIA PYLORIS INFECTION
UndeterminedCY1126238T1Helicobacter InfectionsMicrobiology
Owner:DACF SRL
THERAPEUTIC REGIME AND METHODS OF TREATING MULTIPLE SCLEROSIS USING OFATUMUMABA
UndeterminedCY1126291T1MS multiple sclerosisAntiendomysial antibodies
Owner:NOVARTIS AG
METHODS FOR TREATING AND PREVENTING ATHEROSCLEROSIS BY ADMINISTRATION OF AN ANGPTL3 INHIBITOR
UndeterminedCY1126256T1AntigenAntigen Binding Fragment
Owner:REGENERON PHARMACEUTICALS INC
PRECISION DISTRIBUTION DEVICE FOR LIQUIDS, INCLUDING A DEVICE FOR REMOTE CONTROL AND MONITORING
UndeterminedCY1126273T1Pharmacy medicineRemote control
Owner:L MOLTENI & C DEI FRAT ALITTI SOC DI ESERCIZIO SPA
ADMINISTRATION DEVICES DEVELOPED FROM ADENOVIRUS CAPSID PROTEIN
UndeterminedCY1126003T1Pentameric proteinDelivery vehicle
Owner:EURO LAB FUER MOLEKULARBIOLOGIE EMBL
PALLET BLOCK, PALLET INCLUDING PALLET BLOCKS AND PROCEDURE FOR RECEIVING PALLET BLOCKS AND PALLET
UndeterminedCY1126210T1Pallet collarWood fibre
Owner:MADECA MADEIRAS DE CAXARIAS
IMPROVING SAFETY FOR UV APPLICATIONS BY MONITORING CHANGES IN UV UNCOUPLING
UndeterminedCY1125648T1Control systemOptical transducers
Owner:KONINKLIJKE PHILIPS NV
SOMATOSTATIN REGULATORS AND THEIR USES
UndeterminedCY1125671T1DiseasePharmaceutical drug
Owner:CRINETICS PHARMACEUTICALS INC
BENZOTHIADIAZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS
UndeterminedCY1125791T1Glucose utilizationLiver disease
Owner:ALBIREO
5-HT2A AGONISTS FOR USE IN THE THERAPEUTIC TREATMENT OF DEPRESSION
UndeterminedCY1126166T1AgonistTherapeutic treatment
Owner:LOPHORA APS
COMPOSITIONS AND METHODS FOR INCREASING OR ENHANCED TRANSMISSION OF GENE THERAPY VECTORS AND FOR REMOVAL OR REDUCTION OF IMMUNOGLOBURINS
UndeterminedCY1125729T1DiseaseIntravenous gammaglobulin
Owner:GENETHON
COMPOSITIONS FOR THE TREATMENT OF MYELOFIROSIS
UndeterminedCY1125747T1Bone marrow fibrosisFibrosis
Owner:IMPACT BIOMEDICINES INC
BETAISTINE, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND A MONOAMINE OXIDASE INHIBITOR, FOR USE IN THE TREATMENT OR PREVENTION OF ONE OR MORE SYMPTOMS OF VERTIGO IN A SUBJECT
UndeterminedCY1126201T1Amine oxidase inhibitorsDepressant
Owner:INTRABIO LTD
NEW LIPIDS AND LIPID NANOPARTICLE FORMULATIONS FOR NUCLEIC ACIDS DELIVERY
UndeterminedCY1125712T1NanoparticleOrganic chemistry
Owner:ACUITAS THERAPEUTICS INC
DEVICE FOR FRACTIONING OBJECTS AND FRACTIONING METHOD
UndeterminedCY1125756T1Injection portMechanical engineering
Owner:STEM SEL
KEY AND RELATED LOCK
UndeterminedCY1125661T1Mechanical engineeringPhysics
Owner:EVVA SICHERHEITSTECHNOLOGIE GMBH
COMPOSITIONS AND METHODS FOR MUCOSORPTION ABSORPTION
UndeterminedCY1125645T1AmitriptylineOral medication
Owner:TONIX PHARMA HLDG LTD
PD-1 BLOCKAGE WITH NIVOLUMA IN UNTREATED HODGKIN'S LYMPHOMA
UndeterminedCY1126298T1Antiendomysial antibodiesRefractory Hodgkin Lymphoma
Owner:BRISTOL MYERS SQUIBB CO
VEGF / DLL4 BINDING FACTORS AND THEIR USES
UndeterminedCY1125822T1DiseaseAntiendomysial antibodies
Owner:MEREO BIOPHARMA 5 INC
COMPOUND AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS
UndeterminedCY1125811T1IntracellularNanoparticle
Owner:MODERNATX INC
SOLID PHARMACEUTICAL DOSAGE FORM SUITABLE FOR USE AS A MEDICINAL PRODUCT ADMINISTERED WITH DRINKING WATER
UndeterminedCY1126188T1Pharmacy medicineActive agent
Owner:UNIV GENT
P38 KINASE INHIBITORS REDUCE THE EXPRESSION OF DUX4 AND CATAROTIC GENES FOR THE TREATMENT OF PERITONEOSCABOBRACHIO MUSCLE DYSTROPHY (FSHD)
UndeterminedCY1125744T1Abnormal expressionDisease
Owner:FULCRUM THERAPEUTICS INC
MODIFIED RAAV CAPSID PROTEIN FOR GENE THERAPY
UndeterminedCY1126309T1DiseaseArthritis
Owner:MEIRAGTX UK II LTD
SYSTEM FOR ADMINISTERING NITROGEN MONOXIDE TO PATIENTS IN NEED OF IT, THROUGH RESPIRATOR BREATHING GAS TAKING WITH VARIATION AT LEAST IN PRESSURE AND / OR FLOW THROUGH MEASUREMENT OF THE FLOW OF AMPLIFIED THERAPEUTIC GAS (NO)
UndeterminedCY1125651T1Nitrogen monooxideBreathing gas
Owner:MALLINCKRODT PHARMACEUTICALS IRELAND LTD
PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF ATOPIC DERMATITIS CONTAINING AN IL-31 ANTIBODY AS ACTIVE INGREDIENT
UndeterminedCY1127994T1Antiendomysial antibodiesPharmacy medicine
Owner:CHUGAI PHARMA CO LTD
METHOD AND POLYMERIC MATERIAL WITH EXPRESSION-SUPPRESSING OR BLOOD-FEEDING INHIBITING ACTIVITY AGAINST MOSQUITOES
UndeterminedCY1126588T1BiotechnologyDisease
Owner:SYNGENTA PARTICIPATIONS AG
COMPOSITIONS OF MODIFIED HUMAN ARGINASES AND METHODS FOR TREATING CANCER
UndeterminedCY1125990T1Protein compositionPharmaceutical Substances
Owner:AERASE INC
METHOD FOR RECORDING AND CONTINUOUSLY PRODUCING DATA FOR A USER OF A SELF-SERVICE TERMINAL
UndeterminedCY1125754T1Electronic documentInternet privacy
Owner:SCHELD DANIEL
LAACTOBACILLUS REUTERI MM4-1A FOR USE IN THE TREATMENT OR PREVENTION OF AUTISM SPECTRUM DISORDERS
UndeterminedCY1126235T1PhysiologyHigh fat
Owner:BAYLOR COLLEGE OF MEDICINE
PRODUCTS AND METHODS FOR TREATING AMYOTROPHIC MULTIPLE SCLEROSIS
UndeterminedCY1125950T1Enzyme GeneSuperoxide dismutases
Owner:RES INST AT NATIONWIDE CHILDRENS HOSPITAL
PYRROLOTRIAZINE COMPOUNDS THAT ACT AS MNK INHIBITORS
UndeterminedCY1127382T1DepressantEngineering
Owner:JUMBO DRUG BANK CO LTD
HIGHLY PURIFIED SUGARS AND SUGAR COMPOUNDS
UndeterminedCY1125889T1SucroseNanoparticle
Owner:CORIOLIS PHARMA RES GMBH
NOVEL HETEROCYCLIC DERIVATIVES AND THEIR USES
UndeterminedCY1126254T1Autoimmune conditionAutoimmune disease
Owner:C&C RES LAB
PROLONGED-RELEASE COMPOSITIONS FOR INTRA-ARTICULAR APPLICATIONS
UndeterminedCY1127368T1Organic chemistryEnvironmental geology
Owner:NOVARTIS AG
FUNGICIDAL COMPOSITIONS
UndeterminedCY1125848T1BiotechnologyChemical compound
Owner:SYNGENTA PARTICIPATIONS AG
EMERGENCY LOCATION INFORMATION SYSTEM
UndeterminedCY1126315T1Operational systemEmbedded system
Owner:ELI TECH INC
RESERVOIR SYSTEM CONTAINING GLATIRAMER ACETATE
UndeterminedCY1125635T1Pharmaceutical drugEthylic acid
Owner:MAPI PHARMA LTD
RNA INTERFERENCE-MEDIATED INHIBITION OF TMPRSS6
UndeterminedCY1125760T1ThalassemiaNucleic acid
Owner:SILENCE THERAPEUTICS GMBH
INNOVATIVE NANOCOMPOSITE MATERIALS
UndeterminedCY1126275T1Polymer scienceFirming agent
Owner:NAT CENT FOR SCI RES DEMOKRITOS
BENDING MACHINE WITH ECCENTRIC FOR AN ORTHOPAEDIC ROD
UndeterminedCY1125532T1Classical mechanicsStructural engineering
Owner:SAFE ORTHOPAEDICS SAS
PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF ATOPIC DERMATITIS CONTAINING AN IL-31 ANTIBODY AS ACTIVE INGREDIENT
UndeterminedCY2025029I1Antiendomysial antibodiesPharmacy medicine
Owner:ΔΙΚΑΙΟΎΧΟΥ
PEGYLATED LIPOSOMES FOR DELIVERY OF RNA ENCODING AN IMMUNOGEN
UndeterminedCY1125799T1DiseaseLipofectamine
Owner:GLAXOSMITHKLINE BIOLOGICALS SA
HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASES
UndeterminedCY1125719T1DiseaseMedicinal chemistry
Owner:OPPILAN PHARMA LTD
METHODS FOR THE PREPARATION OF INJECTABLE STOCK COMPOSITIONS
UndeterminedCY1126153T1Glycolic acidPharmaceutical drug
Owner:LAB FARM ROVI SA
CABINET WITH DRAWER DRAWERS AND RELATED DRAWER MECHANISM WITH IMPROVED GUIDE
UndeterminedCY1125982T1CantileverMechanical engineering
Owner:INOXA
DE-SALT COMPOUND FOR TOILETRIES
UndeterminedCY1125776T1Polymer scienceOrganic chemistry
Owner:BOLTON MANITOBA SPA
SELECTIVE ESTROGEN RECEPTOR BANNERS
UndeterminedCY1125838T1Pharmaceutical drugEstrogen receptor
Owner:ELI LILLY & CO
INSTRUMENTS AND METHODS FOR DETERMINING THE PROFILE OF A GLYCOPROTEIN
UndeterminedCY1126198T1Antiendomysial antibodiesCancers diagnosis
Owner:GLYCANOSTICS SRO
RNA CONTAINING MODIFIED NUCLEOSITES AND METHODS OF USING THE SAME
UndeterminedCY1125768T1PolyribonucleotidesPseudouridine
Owner:THE TRUSTEES OF THE UNIV OF PENNSYLVANIA
RESAMPLING AN AUDIO SIGNAL FOR LOW-LATTERY ENCODING / DECODING
UndeterminedCY1125841T1Pattern recognitionEngineering
Owner:KONINKLIJKE PHILIPS NV
CYTOmegaly virus antigens and their uses
UndeterminedCY1125839T1Cytomegalovirus antigenBiochemistry
Owner:GLAXOSMITHKLINE BIOLOGICALS SA
METHOD FOR SORTING MIXED OBJECTS IN A TARGET PALETTE
UndeterminedCY1125795T1Process engineeringPattern generation
Owner:FELLNER HERBERT
IMPROVED SYNTHETIC METHODS FOR THE PREPARATION OF FUSED HETEROCYCLIC COMPOUNDS USED AS OREXIN RECEPTOR MODULATORS
UndeterminedCY1126987T1BiochemistryMolecular biology
Owner:JANSSEN PHARMA NV
CRYSTAL FORMS OF 1-(1,2-DIMETHYLPROPYL)-N- ETHYL-5-METHYL-N-PYRIDAZIN-4-YL-PYRAZOLE-4-CARBOXAMIDE
UndeterminedCY1126030T1PyridazineEthyl group
Owner:BASF SE
A PHARMACEUTICAL COMPOSITION FOR ENHANCING IRON LEVELS IN THE BLOOD, COMPRISING IRON(III) POLYMALTOSE AND ANOTHER ACTIVE SUBSTANCE, SUITABLE FOR IRON ABSORPTION, SELECTED FROM CALCIUM FOLICATE PENTAHYDRATE, VITAMIN C OR A COMBINATION OF BOTH
UndeterminedCY1126306T1Vitamin CIron levels
Owner:TSETI IOULIA
HYBRID CRISPR DNA / RNA POLYNUCLEOTIDES AND METHODS OF USE
UndeterminedCY1126232T1PolynucleotideGenomic clone
Owner:CARIBOU BIOSCIENCES INC
ENHANCEMENT OF THE EFFECT OF MODIFIED CAR T-LYMPHOCYTES THROUGH VACCINATION WITH NUCLEIC ACIDS
UndeterminedCY1126187T1Antigen receptorVaccination
Owner:TRON TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG UNIV MAINZ GEMEINNUETZIGE GMBH
LABORATORY DEVICE WITH ADJUSTABLE OPERATING PARAMETERS FOR CONTROLLING A LABORATORY DEVICE
UndeterminedCY1127238T1Experimental laboratoryLaboratory device
Owner:HANS HEIDOLPH GMBH
EXOBODY COMPOSITIONS AND METHODS OF PREPARING AND USING THEM FOR REGULATING AND CARE OF SKIN AND HAIR
UndeterminedCY1126178T1Skin integrityHeat shock stress
Owner:EXOTROPIN LLC
IMPROVED LIPID NANOPARTICLES FOR NUCLEIC ACIDS RELEASE
UndeterminedCY1127168T1NanoparticleBiomedical engineering
Owner:ACUITAS THERAPEUTICS INC
ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND THEIR USES
UndeterminedCY1126313T1Antiendomysial antibodiesAmyloid beta
Owner:ELI LILLY & CO
ALDOSE REDUCTION INHIBITORS AND THEIR USES
UndeterminedCY1125692T1Diabetic retinopathyRenal disorder
Owner:THE TRUSTEES OF COLUMBIA UNIV IN THE CITY OF NEW YORK
MULTILAMALMATIC MICROPARTILE RELEASE OF PHARMACEUTICALLY ACTIVE COMPOUND IN A LIQUID DOSAGE FORM
UndeterminedCY1125902T1Oral medicationPharmaceutical drug
Owner:BE PHARBEL MFG
A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ANEMIA IN A SUITABLE CONTAINER, WHICH KEEPS THE ACTIVE INGREDIENTS SEPARATE IN A SEALED MANNER: THE IRON COMPLEX WITH N-ACETYL-L-ASPARTIC CASEIN AND CALCIUM FOLIATE PENTAHYDRATE
UndeterminedCY1126155T1BULK ACTIVE INGREDIENTPharmaceutical Substances
Owner:TSETI IOULIA
CHIMERIC ANTIGEN RECEPTOR SPECIFIC FOR CD19 AND USES THEREOF
UndeterminedCY1125956T1Antigen receptorBiochemistry
Owner:CELLECTIS SA
FIXING PROFILE ALLOWING AIR PASSAGE AND SUSPENDED CEILING DEVICE INCLUDING SUCH A PROFILE
UndeterminedCY1125726T1Mechanical engineeringDropped ceiling
Owner:SCHERRER JEAN MARC
MACROCYCLES AS MODULATORS OF TRANSMEMBRANE CONDUCTANCE REGULATOR IN CYSTIC FIBROSUS, PHARMACEUTICAL COMPOSITIONS THEREOF, THEIR USE IN THE TREATMENT OF CYSTIC FIBROSUS, AND METHOD FOR MANUFACTURING THEM
UndeterminedCY1125845T1MetabolitePharmacy medicine
Owner:VERTEX PHARMACEUTICALS INC
LIXISENATIDIS COMPOSITION WITH COVER
UndeterminedCY1125758T1EngineeringOrganic chemistry
Owner:SANOFI AVENTIS DEUT GMBH
METHODS AND COMPOSITIONS FOR TREATING COMPLEMENT-RELATED DISORDERS
UndeterminedCY1126173T1AntigenDisease
Owner:ALEXION PHARMACEUTICALS INC
4-PYRASIN-2-YLMETHYL-MORPHOLINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS
UndeterminedCY1125883T1DiseaseMorpholine
Owner:BOEHRINGER INGELHEIM INT GMBH
CONDUIT FOR SMART BUILDINGS, MACHINE FOR HELICAL WINDING OF CONDUITS FOR SMART BUILDINGS AND WINDING METHOD THEREFOR
UndeterminedCY1125604T1Compression moldingWinding machine
Owner:ZHONGSHI PIPE IND CO LTD
CROSS-LINKED CATION EXCHANGE POLYMERS, COMPOSITIONS AND USE IN THE TREATMENT OF HYPERKALAMIEMIA
UndeterminedCY1125850T1Polymer sciencePolyol
Owner:VIFOR (INT) AG
USE OF PHARMACEUTICAL FORMS OF TANNINS AGAINST BACTERIAL AND FUNGAL DISEASES IN PLANTS
UndeterminedCY1125859T1Fungal diseaseAntimicrobial drug
Owner:QUIMICA AGRONOMICA DE MEXICO S DE R L DE CV
HUMANIZED AND CHIMERIC MONOCLONAL ANTIBODIES AGAINST CD47
UndeterminedCY1125912T1Antiendomysial antibodiesPharmaceutical drug
Owner:THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV
ELECTRONIC ANTI-TAMPER DEVICE
UndeterminedCY1126006T1Tamper resistanceTelecommunications
Owner:BLUESKYTEC LTD
COMPOSITION FOR THE PREVENTION AND TREATMENT OF HAIR DISORDERS
UndeterminedCY1126237T1ThiazoleHair growth
Owner:GIULIANI SPA
GAS SENSOR CATHETER WITH GAS PURGE PROTECTION
UndeterminedCY1125750T1Physical chemistryEngineering
Owner:DANFOSS IXA
PHOTOBIOREACTOR AND METHOD FOR CULTURE OF MICROALGAE
UndeterminedCY1126571T1BiotechnologyMicroorganism
Owner:BECO INVEST BV
ANTI-TRANSTHYRETIN ANTIBODIES
UndeterminedCY1125972T1DiseaseAntiendomysial antibodies
Owner:UNIV HEALTH NETWORK
WATER TREATMENT METHODS AND DEVICE
UndeterminedCY1126679T1Water desalinationSensor array
Owner:SYNAUTA INC
LITHIUM HYDROXIDE RECOVERY METHOD
UndeterminedCY1125634T1Lithium oxideAlkaline earth metal
Owner:METSO OUTOTEC FINLAND OY
MODIFIED AAV CAPSID PROTEINS FOR THERAPEUTIC TREATMENT OF ARTHRITIS DISEASE
UndeterminedCY1127356T1DiseaseArthritis
Owner:MEIRAGTX UK II LTD
CRYSTALLINE SALTS OF AN EPOXYKETON PEPTIDE IMMUNOPROTEABODY INHIBITOR
UndeterminedCY1126029T1Antibody inhibitorCombinatorial chemistry
Owner:KEZAR LIFE SCI
COMPOUNDS AND THEIR CONJUGATIONS
UndeterminedCY1125757T1Antiendomysial antibodiesChemical compound
Owner:MEDIMMUNE LTD
TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS
UndeterminedCY1127186T1
Owner:BRISTOL MYERS SQUIBB CO